LASIK increases night-time halos

Article

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Cesar Villa Collar from the Clinica Oftalmologica Novovision, Spain and colleagues conducted a prospective, observational, analytical study to evaluate the changes in correlations of higher order aberrations (HOAs) of the first corneal surface with halo phenomena under night vision conditions. A total of 11 eyes that had undergone successful LASIK for myopia and astigmatism were examined. Preoperative sphere was -3.48±1.70 D and preoperative cylinder was -0.86±0.87 D. Visual disturbances and pupil size were measured after adaptation to a dark environment.

The halo disturbance index increased by a factor of 2.15 after successful LASIK surgery and total RMS for monochromatic HOA displayed a significant correlation with the halo disturbance index (r=0.36; p<0.01). However, only secondary astigmatism (r=0.36; p<0.01), coma (r=0.25; p=0.02) and spherical aberration (r=0.40; p<0.01) were responsible for this behaviour, with the remaining corneal aberrations until the 6th order not displaying any significant correlation.

It was concluded that LASIK can cause an increase in halos even when the results of the surgery are considered entirely satisfactory according to current international standards of predictability, efficacy and safety.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.